3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
4
Recruiting
3
Not yet recruiting
2
Withdrawn
1
Unknown
1
Terminated
1
Suspended
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Melanoma
6
Lung Neoplasms
6
Prostatic Neoplasms
5
Breast Neoplasms
5
Multiple Myeloma
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Ovarian Neoplasms
3
Osteosarcoma
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myeloid, Acute
3
Barrett Esophagus
3
Urinary Bladder Neoplasms
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Leukemia, Biphenotypic, Acute
2
Gastroesophageal Reflux
2
Central Nervous System Neoplasms
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Adenocarcinoma Of Esophagus
2
Wilms Tumor
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urethral Neoplasms
1
Interventions
Fluorouracil
128
Leucovorin
120
Oxaliplatin
101
Irinotecan
89
Bevacizumab
55
Cetuximab
44
Capecitabine
40
Folfox protocol
29
Panitumumab
22
Colonoscopy
17
Chemotherapy, Adjuvant
16
Floxuridine
15
Early Intervention, Educational
15
Erlotinib Hydrochloride
13
Surveys and Questionnaires
11
IFL protocol
11
Counseling
11
Immunohistochemistry
10
Gemcitabine
10
Celecoxib
10
Psychiatric Rehabilitation
9
Methods
8
Magnetic Resonance Spectroscopy
8
Gene Expression Profiling
8
Exercise
8
Dexamethasone
8
sargramostim
7
Sorafenib
7
Radiotherapy
7
Nivolumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Colonic Neoplasms
×
Specimen Handling
×
Clear all
NCT02243267
2017-11-08
GI SPORE Colon Biosample Protocol
University of Michigan
Completed
115 enrolled